Constitutive activation of Wnt/β‐catenin signaling initiates the growth of benign adenomas, while mutations in KRas, BRaf, and related pathways stimulate adenoma growth and contribute to invasive and other malignant behaviors. This evidence concerns the gene KRAS and adenoma.